These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16897762)

  • 1. Do carbamates cause polyneuropathy?
    Lotti M; Moretto A
    Muscle Nerve; 2006 Oct; 34(4):499-502. PubMed ID: 16897762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble phenyl valerate esterases of hen sciatic nerve and the potentiation of organophosphate induced delayed polyneuropathy.
    Gambalunga A; Pasqualato F; Lotti M
    Chem Biol Interact; 2010 Sep; 187(1-3):340-3. PubMed ID: 20097189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy.
    Lotti M; Moretto A; Capodicasa E; Bertolazzi M; Peraica M; Scapellato ML
    Toxicol Appl Pharmacol; 1993 Oct; 122(2):165-71. PubMed ID: 8211998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phosphorothioic acid O-(2-chloro-2,3,3-trifluorocyclobutyl) O-ethyl S-propyl ester exacerbates organophosphate polyneuropathy without inhibition of neuropathy target esterase.
    Moretto A; Bertolazzi M; Lotti M
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):133-7. PubMed ID: 7974486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between isofenphos cholinergic toxicity and the development of polyneuropathy in hens and humans.
    Moretto A; Lotti M
    Arch Toxicol; 2002 Jun; 76(5-6):367-75. PubMed ID: 12107655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The search of the target of promotion: Phenylbenzoate esterase activities in hen peripheral nerve.
    Moretto A; Nicolli A; Lotti M
    Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):196-201. PubMed ID: 17207828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of neurotoxic esterase in vitro by novel carbamates.
    Randall JC; Ambroso JL; Groutas WC; Brubaker MJ; Richardson RJ
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):173-8. PubMed ID: 9073605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy.
    Milatovic D; Moretto A; Osman KA; Lotti M
    Chem Res Toxicol; 1997 Sep; 10(9):1045-8. PubMed ID: 9305588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing for organophosphate-induced delayed polyneuropathy.
    Moretto A
    Curr Protoc Toxicol; 2001 May; Chapter 11():Unit11.5. PubMed ID: 20957642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicological assessment of isomeric pesticides: a strategy for testing of chiral organophosphorus (OP) compounds for delayed polyneuropathy in a regulatory setting.
    Battershill JM; Edwards PM; Johnson MK
    Food Chem Toxicol; 2004 Aug; 42(8):1279-85. PubMed ID: 15207378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organophosphate induced delayed polyneuropathy.
    Jokanovic M; Stukalov PV; Kosanovic M
    Curr Drug Targets CNS Neurol Disord; 2002 Dec; 1(6):593-602. PubMed ID: 12769600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosensor assay of neuropathy target esterase in whole blood as a new approach to OPIDN risk assessment: review of progress.
    Makhaeva GF; Malygin VV; Strakhova NN; Sigolaeva LV; Sokolovskaya LG; Eremenko AV; Kurochkin IN; Richardson RJ
    Hum Exp Toxicol; 2007 Apr; 26(4):273-82. PubMed ID: 17615108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organophosphate-induced delayed polyneuropathy.
    Lotti M; Moretto A
    Toxicol Rev; 2005; 24(1):37-49. PubMed ID: 16042503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoters and promotion of axonopathies.
    Moretto A
    Toxicol Lett; 2000 Mar; 112-113():17-21. PubMed ID: 10720708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling cholinesterase activity for human dietary risk assessment of carbamate insecticides.
    Williams RL; Mihlan GJ; Tobia AJ
    Risk Anal; 2008 Aug; 28(4):1069-79. PubMed ID: 18631301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical and electrophysiological features of a delayed polyneuropathy developing subsequently after acute organophosphate poisoning and it's correlation with the serum acetylcholinesterase.
    Aygun D; Onar MK; Altintop BL
    Electromyogr Clin Neurophysiol; 2003; 43(7):421-7. PubMed ID: 14626722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorpyrifos-induced delayed polyneuropathy.
    Capodicasa E; Scapellato ML; Moretto A; Caroldi S; Lotti M
    Arch Toxicol; 1991; 65(2):150-5. PubMed ID: 1711837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lead arsenate as an underestimated cause of polyneuropathy in rural environment: description of two cases].
    Foà V; Gilioli R; Rizzi B; Merluzzi F
    Riv Patol Nerv Ment; 1976; 96(6):363-77. PubMed ID: 1023347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTE: one target protein for different toxic syndromes with distinct mechanisms?
    Glynn P
    Bioessays; 2003 Aug; 25(8):742-5. PubMed ID: 12879443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pesticide poisoning of farm workers-implications of blood test results from Vietnam.
    Dasgupta S; Meisner C; Wheeler D; Xuyen K; Thi Lam N
    Int J Hyg Environ Health; 2007 Mar; 210(2):121-32. PubMed ID: 17008128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.